Skip to main navigation Skip to search Skip to main content

Biomarkers and Functional Decline in Prodromal Alzheimer's Disease

  • Catherine Robb
  • , Chinedu Udeh-Momoh
  • , Stefan Wagenpfeil
  • , Jakob Schöpe
  • , Panagiotis Alexopoulos
  • , Robert Perneczky
  • , for the Alzheimer’s Disease Neuroimaging Initiative (ADNI)

Research output: Contribution to journal › Article › Research › peer-review

Abstract

Background: Little is known of possible associations between Alzheimer's disease (AD) biomarkers and instrumental activities of daily living (IADL) change over time. Objective: The present study seeks to identify relationships between baseline imaging and fluid biomarker profiles, and decline in IADL utilizing data collated from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Methods: Generalized estimating equations analysis, adjusted for cognitive deterioration, was applied to a cohort of 509 individuals from all stages of ADNI, including 156 healthy controls, 189 early mild cognitive impairment (MCI) patients and 164 MCI patients. Results: A significant correlation was found between baseline biomarkers, specifically CSF Aβ and FDG PET, and IADL change over a 3-year period in individuals with MCI. Importantly, comparable correlations between presence of pathological biomarker levels and temporal decline in both functional and cognitive performance were also noted. Discussion: We show that distinct baseline biomarkers may predict latent changes in IADL. Our results necessitate a revision of the commonly held view upholding cognitive changes as the predominant endpoint measure associated with presence of abnormal baseline biomarkers.

Original languageEnglish
Pages (from-to)69-78
Number of pages10
JournalJournal of Alzheimer's Disease
Volume58
Issue number1
DOIs
Publication statusPublished - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Activities of daily living
  • Alzheimer's disease
  • biomarker
  • cerebrospinal fluid
  • early diagnosis
  • magnetic resonance imaging
  • positron emission tomography
  • prediction

Cite this